Cardiac tissue engineering has the potential to develop regenerative therapies for damaged myocardium, but due to the complex structure and composition of the tissue in both healthy and diseased states, a clinical solution has not been realized. Human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) are self- renewing, pluripotent cell sources that can potentially generate an unlimited number of cardiomyocytes (CMs). However, the clinical application of these cells is hampered by the limited knowledge of 1) the long-term ability of transplanted cells to maintain a therapeutic effect and 2) the eventual fate of these still very immature cells. Identifying the biochemical and physical factors that govern cardiac ...
Myocardial infarction (MI) prompts a substantial loss of cardiomyocytes (CM) in the human heart, an ...
International audienceHuman induced pluripotent stem cells (hiPSC) have become one of the most promi...
Cardiac tissues generated from human induced pluripotent stem cells (iPSCs) can serve as platforms f...
The use of induced pluripotent stem cell (iPSC)-derived cardiomyocytes (CM) has great potential for ...
The adult human heart has a minimal ability to regenerate myocardium. Therefore, loss of viable card...
Human induced pluripotent stem cells (hiPSCs) are a robust source for cardiac regenerative therapy d...
Background—Cardiomyocytes derived from human embryonic stem (hES) cells could be useful in restoring...
Thesis (Ph.D.)--University of Washington, 2014Cardiac tissue engineering enables the generation of f...
While cardiomyocytes derived from human pluripotent stem cells (hPSC-CMs) represent a promising popu...
<div><p>The mammalian heart has little capacity to regenerate, and following injury the myocardium i...
The concept of tissue-restricted differentiation of postnatal stem cells has been challenged by rece...
BACKGROUND:Delivery of stem cells to the failing heart is a promising therapeutic strategy. However,...
Cardiovascular disease (CVD) is the most prevalent health problem in the world, and the high mortali...
Human-induced pluripotent stem cells (hiPSCs) are reprogrammed cells that have hallmarks similar to ...
Cardiovascular disorders are currently the leading cause of death in the Western world. Myocardial i...
Myocardial infarction (MI) prompts a substantial loss of cardiomyocytes (CM) in the human heart, an ...
International audienceHuman induced pluripotent stem cells (hiPSC) have become one of the most promi...
Cardiac tissues generated from human induced pluripotent stem cells (iPSCs) can serve as platforms f...
The use of induced pluripotent stem cell (iPSC)-derived cardiomyocytes (CM) has great potential for ...
The adult human heart has a minimal ability to regenerate myocardium. Therefore, loss of viable card...
Human induced pluripotent stem cells (hiPSCs) are a robust source for cardiac regenerative therapy d...
Background—Cardiomyocytes derived from human embryonic stem (hES) cells could be useful in restoring...
Thesis (Ph.D.)--University of Washington, 2014Cardiac tissue engineering enables the generation of f...
While cardiomyocytes derived from human pluripotent stem cells (hPSC-CMs) represent a promising popu...
<div><p>The mammalian heart has little capacity to regenerate, and following injury the myocardium i...
The concept of tissue-restricted differentiation of postnatal stem cells has been challenged by rece...
BACKGROUND:Delivery of stem cells to the failing heart is a promising therapeutic strategy. However,...
Cardiovascular disease (CVD) is the most prevalent health problem in the world, and the high mortali...
Human-induced pluripotent stem cells (hiPSCs) are reprogrammed cells that have hallmarks similar to ...
Cardiovascular disorders are currently the leading cause of death in the Western world. Myocardial i...
Myocardial infarction (MI) prompts a substantial loss of cardiomyocytes (CM) in the human heart, an ...
International audienceHuman induced pluripotent stem cells (hiPSC) have become one of the most promi...
Cardiac tissues generated from human induced pluripotent stem cells (iPSCs) can serve as platforms f...